Porton Pharma Solutions and Codexis Launch Global Partnership
Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business. [...]